Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tom Bijl"'
Autor:
Jelle van Schooten, Elinaz Farokhi, Anna Schorcht, Tom L. G. M. van den Kerkhof, Hongmei Gao, Patricia van der Woude, Judith A. Burger, Tim G. Rijkhold Meesters, Tom Bijl, Riham Ghalaiyini, Hannah L. Turner, Jessica Dorning, Barbera D. C. van Schaik, Antoine H. C. van Kampen, Celia C. Labranche, Robyn L. Stanfield, Devin Sok, David C. Montefiori, Dennis R. Burton, Michael S. Seaman, Gabriel Ozorowski, Ian A. Wilson, Rogier W. Sanders, Andrew B. Ward, Marit J. van Gils
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
HIV-1 vaccine design aims to induce broadly neutralizing antibodies such as IOMA, the only described antibody in its class. Here, the authors present the isolation, characterisation and structure of three additional antibodies within the IOMA class
Externí odkaz:
https://doaj.org/article/00bf4f4cc60648ceb42fb07282abd785
Autor:
Jelle van Schooten, Anna Schorcht, Elinaz Farokhi, Jeffrey C Umotoy, Hongmei Gao, Tom L G M van den Kerkhof, Jessica Dorning, Tim G Rijkhold Meesters, Patricia van der Woude, Judith A Burger, Tom Bijl, Riham Ghalaiyini, Alba Torrents de la Peña, Hannah L Turner, Celia C Labranche, Robyn L Stanfield, Devin Sok, Hanneke Schuitemaker, David C Montefiori, Dennis R Burton, Gabriel Ozorowski, Michael S Seaman, Ian A Wilson, Rogier W Sanders, Andrew B Ward, Marit J van Gils
Publikováno v:
PLoS Pathogens, Vol 18, Iss 11, p e1010945 (2022)
Broadly neutralizing antibodies (bNAbs) have remarkable breadth and potency against most HIV-1 subtypes and are able to prevent HIV-1 infection in animal models. However, bNAbs are extremely difficult to induce by vaccination. Defining the developmen
Externí odkaz:
https://doaj.org/article/9a8650aeeb2e4e9db4484031f5c06256